@article{oai:nagasaki-u.repo.nii.ac.jp:00027585, author = {Ueda, Mayu and Matsuda, Katsuya and Kurohama, Hirokazu and Mussazhanova, Zhanna and Sailaubekova, Yerkezhan and Kondo, Hisayoshi and Shimizu, Tomoki and Takada, Nami and Matsuoka, Yuki and Otsubo, Chieko and Sato, Shinya and Yamashita, Hiroyuki and Kawakami, Atsushi and Nakashima, Masahiro}, issue = {15}, journal = {Cancers}, month = {Jul}, note = {Thyroid follicular-patterned tumors (TFTs) showing nodule-in-nodule (NN) appearance with poorly differentiated component (PDc) but neither invasion nor metastasis are diagnosed as benign nodules. Although PDc exhibits histologically aggressive features relative to the outer nodule (Out-N), its pathological significance remains unclear. TP53 binding protein-1 (53BP1) is a DNA damage response (DDR) molecule that rapidly localizes at DNA double-strand breaks. Using dualcolor immunofluorescence with Ki-67, the profile of 53BP1 expression is shown to be significantly altered during diverse tumorigenesis. In this study, we aimed to elucidate the malignant potential of PDc at the molecular level. We analyzed the profile of 53BP1 expression and NRAS codon 61 and TERT-promoter (TERT-p) mutations in 16 cases of TFTs showing NN with PDc compared to 30 adenomatous goiters, 31 follicular adenomas, 15 minimally invasive follicular carcinomas (FCs), and 11 widely invasive FC cases. Our results revealed that the expression level of abnormal type 53BP1 and incidence of NRAS and TERT-p mutations in PDc were comparable to FCs, suggesting a malignant potential. Because co-expression of 53BP1 and Ki-67 can be an indicator of altered DDR, the development of PDc in NN may be associated with DDR impairments after harboring NRAS and TERT-p mutations., Cancers, 14(15), art. no. 3577; 2022}, title = {Molecular Pathological Characteristics of Thyroid Follicular-Patterned Tumors Showing Nodule-in-Nodule Appearance with Poorly Differentiated Component}, volume = {14}, year = {2022} }